Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Lumos Pharma Inc shares valued at $6,426 were sold by McKew John C. on Aug 06 ’24. At $1.89 per share, McKew John C. sold 3,407 shares. The insider’s holdings dropped to 12,653 shares worth approximately $49979.350000000006 following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, McKew John C. sold 2,214 shares, netting a total of over 6,144 in proceeds. Following the sale of shares at $2.77 each, the insider now holds 17,153 shares.
Before that, McKew John C. had sold 438 shares from its account. In a trade valued at $1,328, the Chief Scientific Officer traded Lumos Pharma Inc shares for $3.03 each. Upon closing the transaction, the insider’s holdings decreased to 438 shares, worth approximately $72691.85.
As published in a research note from Stifel on March 11, 2021, Lumos Pharma Inc [LUMO] has been rated up from a Hold to a Buy and the price target has been revised to $24 from $4. Analysts at Cantor Fitzgerald started covering the stock with ‘”a Buy”‘ outlook in a report released in early December. As of August 26, 2020, Piper Sandler has initiated its “an Overweight” rating for LUMO.
Analyzing LUMO Stock Performance
During the last five days, there has been a surge of approximately 1.28%. Over the course of the year, Lumos Pharma Inc shares have jumped approximately 24.21%. Shares of the company reached a 52-week high of $4.40 on 08/26/24 and a 52-week low of $1.37 on 07/10/24. A 50-day SMA is recorded $2.35, while a 200-day SMA reached $2.71. Nevertheless, trading volume fell to 0.28 million shares from 93100.0 shares the previous day.
Support And Resistance Levels for Lumos Pharma Inc (LUMO)
According to the 24-hour chart, there is a support level at 3.78, which, if violated, would cause prices to drop to 3.61. In the upper region, resistance lies at 4.07. The next price resistance is at 4.19. RSI (Relative Strength Index) is 78.19 on the 14-day chart, showing overbought technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.43, which suggests the price will decrease in the coming days. Percent R is at 21.81%, indicating bullish price movement. Stochastics %K at holding indicates that the stock is to be held.
Which companies own the most shares of Lumos Pharma Inc (LUMO)?
On August 04, 2020, H.C. Wainwright assigned a price target of “a Buy” to the stock and initiated coverage with a $33.
